Gene Symbol | Gene ID | Gene Info |
---|---|---|
Sox3
|
ENSMUSG00000045179.8 | Sox3 |
Sox10
|
ENSMUSG00000033006.9 | Sox10 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
Sox10 | chr15_79159930_79161178 | 3920 | 0.110590 | 0.37 | 3.5e-03 | Click! |
Sox10 | chr15_79159072_79159621 | 5128 | 0.100893 | 0.33 | 1.0e-02 | Click! |
Sox10 | chr15_79161476_79163015 | 2229 | 0.153745 | 0.28 | 2.9e-02 | Click! |
Sox10 | chr15_79161202_79161377 | 3185 | 0.121821 | 0.18 | 1.6e-01 | Click! |
Sox10 | chr15_79158220_79158371 | 6179 | 0.096161 | 0.14 | 2.8e-01 | Click! |
Sox3 | chrX_60891586_60891737 | 1769 | 0.275944 | 0.67 | 6.3e-09 | Click! |
Sox3 | chrX_60892404_60893251 | 603 | 0.520692 | 0.58 | 1.2e-06 | Click! |
Sox3 | chrX_60893251_60893524 | 43 | 0.776350 | 0.57 | 1.8e-06 | Click! |
Sox3 | chrX_60890286_60890534 | 3020 | 0.208742 | 0.56 | 2.6e-06 | Click! |
Sox3 | chrX_60891819_60892374 | 1334 | 0.330355 | 0.49 | 6.4e-05 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_29143400_29144848 | 18.99 |
Soga3 |
SOGA family member 3 |
65 |
0.5 |
chr8_70119024_70120981 | 14.83 |
Ncan |
neurocan |
871 |
0.35 |
chr8_123413418_123414506 | 13.45 |
Tubb3 |
tubulin, beta 3 class III |
2372 |
0.11 |
chrX_143930842_143933141 | 13.08 |
Dcx |
doublecortin |
1059 |
0.64 |
chr8_123410787_123412789 | 12.45 |
Tubb3 |
tubulin, beta 3 class III |
198 |
0.84 |
chr13_20473087_20474265 | 11.74 |
Gm32036 |
predicted gene, 32036 |
186 |
0.89 |
chr15_72807706_72808811 | 11.73 |
Peg13 |
paternally expressed 13 |
2066 |
0.4 |
chr9_52148115_52149635 | 11.68 |
Zc3h12c |
zinc finger CCCH type containing 12C |
19236 |
0.18 |
chr1_136132801_136134260 | 11.48 |
Kif21b |
kinesin family member 21B |
2076 |
0.19 |
chr10_80300884_80302968 | 10.86 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
106 |
0.9 |
chr8_41054476_41055299 | 10.80 |
Mtus1 |
mitochondrial tumor suppressor 1 |
93 |
0.95 |
chr2_6883618_6884699 | 10.71 |
Gm13389 |
predicted gene 13389 |
112 |
0.85 |
chr4_5724213_5725550 | 10.55 |
Fam110b |
family with sequence similarity 110, member B |
569 |
0.81 |
chr13_34126566_34127191 | 9.96 |
Tubb2b |
tubulin, beta 2B class IIB |
3476 |
0.13 |
chr14_66344363_66345813 | 9.89 |
Stmn4 |
stathmin-like 4 |
707 |
0.65 |
chr1_177446374_177448525 | 9.89 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
1628 |
0.31 |
chr8_41052368_41053980 | 9.55 |
Gm16193 |
predicted gene 16193 |
64 |
0.96 |
chr10_34299043_34301066 | 9.50 |
Tspyl4 |
TSPY-like 4 |
798 |
0.4 |
chr11_76466993_76468433 | 9.50 |
Abr |
active BCR-related gene |
585 |
0.77 |
chr5_88583963_88584847 | 9.47 |
Rufy3 |
RUN and FYVE domain containing 3 |
611 |
0.7 |
chr4_134470669_134471383 | 8.93 |
Stmn1 |
stathmin 1 |
1284 |
0.28 |
chr17_93198991_93201483 | 8.87 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
302 |
0.89 |
chr8_54954519_54955779 | 8.60 |
Gpm6a |
glycoprotein m6a |
306 |
0.88 |
chr3_34652462_34653573 | 8.57 |
Sox2 |
SRY (sex determining region Y)-box 2 |
2612 |
0.16 |
chr15_98983254_98984205 | 8.25 |
4930578M01Rik |
RIKEN cDNA 4930578M01 gene |
102 |
0.93 |
chr6_13835523_13837039 | 8.19 |
Gpr85 |
G protein-coupled receptor 85 |
960 |
0.59 |
chr3_8509825_8511666 | 8.14 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr2_158606690_158608449 | 7.95 |
Gm14204 |
predicted gene 14204 |
3021 |
0.15 |
chr3_17791717_17791961 | 7.94 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
1882 |
0.32 |
chr4_116223265_116224130 | 7.85 |
Pik3r3 |
phosphoinositide-3-kinase regulatory subunit 3 |
2001 |
0.23 |
chr1_66322405_66322814 | 7.81 |
Map2 |
microtubule-associated protein 2 |
507 |
0.79 |
chr18_59062200_59063436 | 7.77 |
Minar2 |
membrane integral NOTCH2 associated receptor 2 |
307 |
0.94 |
chr12_72234504_72235243 | 7.68 |
Rtn1 |
reticulon 1 |
866 |
0.66 |
chr9_110053895_110054422 | 7.58 |
Map4 |
microtubule-associated protein 4 |
2106 |
0.22 |
chr13_83717521_83718816 | 7.50 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
3213 |
0.17 |
chr9_106147912_106149765 | 7.48 |
D030055H07Rik |
RIKEN cDNA D030055H07 gene |
151 |
0.9 |
chr19_47017426_47018238 | 7.38 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
2679 |
0.17 |
chr18_16805598_16806159 | 7.33 |
Cdh2 |
cadherin 2 |
2584 |
0.29 |
chr6_134886811_134888239 | 7.32 |
Gpr19 |
G protein-coupled receptor 19 |
243 |
0.87 |
chr15_95525022_95525792 | 7.24 |
Nell2 |
NEL-like 2 |
2771 |
0.35 |
chr4_122998794_122999794 | 7.23 |
Mycl |
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
45 |
0.97 |
chr2_65565600_65566271 | 7.16 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
1557 |
0.45 |
chr19_47016965_47017116 | 7.07 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
1887 |
0.21 |
chr2_65566848_65567533 | 7.01 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
302 |
0.92 |
chr5_19907724_19909563 | 7.00 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
682 |
0.82 |
chr3_108410436_108412210 | 6.97 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
4229 |
0.11 |
chr8_65617917_65619195 | 6.96 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
31 |
0.99 |
chr10_92163758_92164191 | 6.95 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
692 |
0.72 |
chr18_42897053_42897298 | 6.78 |
Ppp2r2b |
protein phosphatase 2, regulatory subunit B, beta |
1640 |
0.46 |
chr12_52699339_52699808 | 6.74 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
190 |
0.95 |
chr12_29528407_29529244 | 6.72 |
Myt1l |
myelin transcription factor 1-like |
424 |
0.85 |
chr13_83740463_83741042 | 6.70 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1889 |
0.2 |
chr9_41378412_41379411 | 6.67 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
2350 |
0.27 |
chr16_18213980_18215144 | 6.64 |
4933432I09Rik |
RIKEN cDNA 4933432I09 gene |
699 |
0.36 |
chr10_18408068_18409081 | 6.63 |
Nhsl1 |
NHS-like 1 |
899 |
0.67 |
chr15_98989928_98991865 | 6.59 |
4930578M01Rik |
RIKEN cDNA 4930578M01 gene |
5002 |
0.1 |
chr6_28828230_28829085 | 6.58 |
Lrrc4 |
leucine rich repeat containing 4 |
1688 |
0.37 |
chr7_45784257_45784949 | 6.58 |
Sult2b1 |
sulfotransferase family, cytosolic, 2B, member 1 |
66 |
0.88 |
chr16_16558986_16560577 | 6.53 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
209 |
0.94 |
chr1_9601164_9602408 | 6.51 |
Vxn |
vexin |
587 |
0.67 |
chr2_158609356_158610186 | 6.46 |
Gm14204 |
predicted gene 14204 |
819 |
0.36 |
chr18_72347538_72348154 | 6.45 |
Dcc |
deleted in colorectal carcinoma |
3171 |
0.38 |
chr2_181134042_181135583 | 6.33 |
Kcnq2 |
potassium voltage-gated channel, subfamily Q, member 2 |
110 |
0.95 |
chr11_41999400_42000640 | 6.32 |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
336 |
0.92 |
chrX_136590440_136591154 | 6.25 |
Tceal3 |
transcription elongation factor A (SII)-like 3 |
45 |
0.96 |
chr12_117688775_117690161 | 6.22 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
512 |
0.83 |
chr3_68573207_68574269 | 6.16 |
Schip1 |
schwannomin interacting protein 1 |
1493 |
0.45 |
chr10_69705909_69707430 | 6.14 |
Ank3 |
ankyrin 3, epithelial |
191 |
0.97 |
chr8_94994139_94995207 | 6.13 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
77 |
0.95 |
chr8_94995272_94995731 | 6.08 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
160 |
0.93 |
chr2_105680581_105683424 | 6.08 |
Pax6 |
paired box 6 |
290 |
0.89 |
chrX_152643367_152644550 | 6.06 |
Shroom2 |
shroom family member 2 |
34 |
0.98 |
chr4_9269280_9270516 | 6.02 |
Clvs1 |
clavesin 1 |
551 |
0.81 |
chr7_51629095_51630495 | 6.02 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
315 |
0.88 |
chr2_181764652_181765649 | 6.01 |
Myt1 |
myelin transcription factor 1 |
1818 |
0.27 |
chr1_194622071_194623282 | 6.01 |
Plxna2 |
plexin A2 |
2851 |
0.26 |
chr14_108912235_108913525 | 6.01 |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
1278 |
0.64 |
chr8_117259792_117260803 | 6.00 |
Cmip |
c-Maf inducing protein |
3180 |
0.33 |
chr5_37245879_37246957 | 6.00 |
Crmp1 |
collapsin response mediator protein 1 |
573 |
0.76 |
chr12_119235620_119236481 | 5.99 |
Itgb8 |
integrin beta 8 |
2720 |
0.31 |
chr7_24485614_24487418 | 5.89 |
Cadm4 |
cell adhesion molecule 4 |
4493 |
0.1 |
chr3_17790851_17791260 | 5.89 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
1098 |
0.49 |
chr18_35212708_35213458 | 5.88 |
Ctnna1 |
catenin (cadherin associated protein), alpha 1 |
1847 |
0.28 |
chr13_109442519_109443753 | 5.86 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
953 |
0.73 |
chr15_25753053_25753722 | 5.86 |
Myo10 |
myosin X |
408 |
0.88 |
chr12_29529828_29531185 | 5.86 |
Gm20208 |
predicted gene, 20208 |
609 |
0.74 |
chr16_77418973_77419718 | 5.82 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
2475 |
0.17 |
chr15_76519928_76521866 | 5.78 |
Scrt1 |
scratch family zinc finger 1 |
1005 |
0.28 |
chr16_77421091_77421970 | 5.78 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
290 |
0.84 |
chrX_23284413_23285126 | 5.76 |
Klhl13 |
kelch-like 13 |
60 |
0.99 |
chr4_22484307_22484937 | 5.76 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
3744 |
0.2 |
chr3_158559356_158560580 | 5.73 |
Lrrc7 |
leucine rich repeat containing 7 |
1368 |
0.57 |
chr13_55484574_55485692 | 5.72 |
Dbn1 |
drebrin 1 |
1164 |
0.26 |
chrX_134295383_134296942 | 5.70 |
Tmem35a |
transmembrane protein 35A |
937 |
0.52 |
chr13_44842150_44842855 | 5.67 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
1719 |
0.39 |
chr13_83741336_83742027 | 5.62 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2818 |
0.16 |
chr19_22447648_22448999 | 5.59 |
Trpm3 |
transient receptor potential cation channel, subfamily M, member 3 |
91 |
0.63 |
chr13_44946654_44947258 | 5.55 |
Dtnbp1 |
dystrobrevin binding protein 1 |
188 |
0.96 |
chr3_88206822_88208169 | 5.53 |
Gm3764 |
predicted gene 3764 |
183 |
0.86 |
chr19_47019038_47019748 | 5.49 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
4240 |
0.14 |
chr4_107679769_107680930 | 5.49 |
Dmrtb1 |
DMRT-like family B with proline-rich C-terminal, 1 |
611 |
0.63 |
chr17_52602081_52603198 | 5.46 |
Gm27217 |
predicted gene 27217 |
21 |
0.54 |
chr9_91366433_91367646 | 5.45 |
Zic1 |
zinc finger protein of the cerebellum 1 |
1229 |
0.26 |
chr6_93911862_93913573 | 5.45 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
213 |
0.95 |
chr5_106453173_106456366 | 5.38 |
Barhl2 |
BarH like homeobox 2 |
3397 |
0.22 |
chr10_18470218_18471289 | 5.37 |
Nhsl1 |
NHS-like 1 |
772 |
0.72 |
chrX_105390628_105392456 | 5.35 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
212 |
0.93 |
chr12_29536509_29537451 | 5.33 |
Myt1l |
myelin transcription factor 1-like |
1758 |
0.36 |
chr8_12399326_12400483 | 5.30 |
Gm25239 |
predicted gene, 25239 |
3501 |
0.16 |
chr10_92164315_92164805 | 5.29 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
106 |
0.97 |
chr13_34128849_34129198 | 5.28 |
Tubb2b |
tubulin, beta 2B class IIB |
1331 |
0.28 |
chr1_32174771_32175297 | 5.22 |
Khdrbs2 |
KH domain containing, RNA binding, signal transduction associated 2 |
2147 |
0.41 |
chr15_77150114_77150989 | 5.21 |
Rbfox2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
3005 |
0.19 |
chrX_58032839_58033176 | 5.19 |
Zic3 |
zinc finger protein of the cerebellum 3 |
1997 |
0.41 |
chr7_62420525_62420893 | 5.19 |
Mkrn3 |
makorin, ring finger protein, 3 |
570 |
0.69 |
chr10_81481482_81482676 | 5.16 |
Celf5 |
CUGBP, Elav-like family member 5 |
593 |
0.47 |
chr13_110279614_110280243 | 5.16 |
Rab3c |
RAB3C, member RAS oncogene family |
222 |
0.95 |
chr9_26735341_26735832 | 5.15 |
B3gat1 |
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
1735 |
0.34 |
chr4_33926104_33927188 | 5.15 |
Cnr1 |
cannabinoid receptor 1 (brain) |
444 |
0.88 |
chr4_116405618_116406369 | 5.14 |
Mast2 |
microtubule associated serine/threonine kinase 2 |
7 |
0.98 |
chr1_157242024_157242632 | 5.14 |
Rasal2 |
RAS protein activator like 2 |
2162 |
0.36 |
chrX_133684830_133685971 | 5.11 |
Pcdh19 |
protocadherin 19 |
409 |
0.91 |
chr4_150651111_150652374 | 5.09 |
Slc45a1 |
solute carrier family 45, member 1 |
355 |
0.88 |
chr2_181763361_181764530 | 5.06 |
Myt1 |
myelin transcription factor 1 |
613 |
0.66 |
chr18_25750468_25751272 | 5.04 |
Celf4 |
CUGBP, Elav-like family member 4 |
1822 |
0.41 |
chr10_111247804_111248910 | 5.04 |
Osbpl8 |
oxysterol binding protein-like 8 |
289 |
0.91 |
chr10_6788358_6789268 | 5.02 |
Oprm1 |
opioid receptor, mu 1 |
4 |
0.99 |
chr1_158363941_158364209 | 5.02 |
Astn1 |
astrotactin 1 |
1525 |
0.4 |
chr9_43070574_43070912 | 5.00 |
Arhgef12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
28111 |
0.16 |
chr3_88211471_88212561 | 5.00 |
Gm3764 |
predicted gene 3764 |
2469 |
0.11 |
chr7_79500711_79501247 | 4.96 |
Mir9-3hg |
Mir9-3 host gene |
858 |
0.39 |
chr3_89763591_89764832 | 4.93 |
Chrnb2 |
cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal) |
397 |
0.76 |
chr7_92234907_92236280 | 4.92 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
466 |
0.88 |
chr5_111424407_111425623 | 4.89 |
Gm43119 |
predicted gene 43119 |
1426 |
0.38 |
chr1_184997307_184998530 | 4.89 |
Mark1 |
MAP/microtubule affinity regulating kinase 1 |
1557 |
0.41 |
chr15_99704098_99705242 | 4.88 |
Gm34939 |
predicted gene, 34939 |
694 |
0.3 |
chr9_22050521_22051976 | 4.87 |
Elavl3 |
ELAV like RNA binding protein 3 |
762 |
0.41 |
chr13_83718912_83719403 | 4.87 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2224 |
0.22 |
chr12_27335791_27336166 | 4.87 |
Sox11 |
SRY (sex determining region Y)-box 11 |
6596 |
0.3 |
chr13_34125172_34126139 | 4.86 |
Tubb2b |
tubulin, beta 2B class IIB |
4699 |
0.12 |
chr4_22491084_22492166 | 4.85 |
Gm30731 |
predicted gene, 30731 |
1077 |
0.46 |
chr8_14382368_14383445 | 4.84 |
Dlgap2 |
DLG associated protein 2 |
910 |
0.66 |
chr9_108824114_108825614 | 4.84 |
Gm35025 |
predicted gene, 35025 |
3 |
0.87 |
chrX_7919510_7921219 | 4.83 |
Pcsk1n |
proprotein convertase subtilisin/kexin type 1 inhibitor |
542 |
0.52 |
chr13_78189592_78191761 | 4.82 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
233 |
0.9 |
chr5_107498769_107499247 | 4.80 |
Btbd8 |
BTB (POZ) domain containing 8 |
1229 |
0.33 |
chr3_88213113_88214199 | 4.80 |
Gm3764 |
predicted gene 3764 |
829 |
0.3 |
chr7_62366760_62367184 | 4.79 |
Magel2 |
melanoma antigen, family L, 2 |
10038 |
0.18 |
chr17_78508180_78509392 | 4.77 |
Vit |
vitrin |
614 |
0.7 |
chr12_12722998_12723739 | 4.76 |
3732407C23Rik |
RIKEN cDNA 3732407C23 gene |
507 |
0.78 |
chr8_109248831_109249717 | 4.72 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
592 |
0.83 |
chr6_137252157_137253458 | 4.72 |
Ptpro |
protein tyrosine phosphatase, receptor type, O |
342 |
0.92 |
chr16_81202167_81203211 | 4.72 |
Ncam2 |
neural cell adhesion molecule 2 |
1932 |
0.44 |
chr5_116590520_116593206 | 4.71 |
Srrm4 |
serine/arginine repetitive matrix 4 |
46 |
0.98 |
chr14_75963198_75963625 | 4.70 |
Kctd4 |
potassium channel tetramerisation domain containing 4 |
8402 |
0.18 |
chr1_139375797_139376462 | 4.67 |
Crb1 |
crumbs family member 1, photoreceptor morphogenesis associated |
912 |
0.52 |
chr5_37241461_37244349 | 4.64 |
Crmp1 |
collapsin response mediator protein 1 |
171 |
0.95 |
chr3_114904046_114905354 | 4.63 |
Olfm3 |
olfactomedin 3 |
65 |
0.98 |
chr14_64574043_64574635 | 4.62 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
12992 |
0.15 |
chr2_6884711_6884884 | 4.59 |
Celf2 |
CUGBP, Elav-like family member 2 |
95 |
0.88 |
chr7_144175485_144176434 | 4.58 |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
430 |
0.88 |
chr1_74892200_74893701 | 4.57 |
Cryba2 |
crystallin, beta A2 |
58 |
0.95 |
chr5_97222612_97223731 | 4.57 |
Gm2861 |
predicted gene 2861 |
27585 |
0.16 |
chr1_25228097_25229399 | 4.56 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
78 |
0.96 |
chr1_66176824_66177184 | 4.54 |
Map2 |
microtubule-associated protein 2 |
1454 |
0.52 |
chr2_178141581_178143125 | 4.51 |
Phactr3 |
phosphatase and actin regulator 3 |
420 |
0.88 |
chr3_88210777_88211200 | 4.51 |
Gm3764 |
predicted gene 3764 |
1516 |
0.18 |
chr7_79505833_79506958 | 4.51 |
Mir9-3 |
microRNA 9-3 |
1131 |
0.28 |
chr4_102761968_102762422 | 4.50 |
Sgip1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
1670 |
0.44 |
chr11_94044930_94045437 | 4.50 |
Spag9 |
sperm associated antigen 9 |
818 |
0.6 |
chr7_99271595_99272046 | 4.49 |
Map6 |
microtubule-associated protein 6 |
2688 |
0.18 |
chr4_13746200_13747057 | 4.49 |
Runx1t1 |
RUNX1 translocation partner 1 |
3192 |
0.37 |
chr4_110285468_110287125 | 4.48 |
Elavl4 |
ELAV like RNA binding protein 4 |
320 |
0.94 |
chr9_41587250_41587725 | 4.46 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
282 |
0.84 |
chr5_111425949_111427685 | 4.44 |
Gm43119 |
predicted gene 43119 |
3228 |
0.22 |
chr5_120433178_120434996 | 4.43 |
Gm27199 |
predicted gene 27199 |
2320 |
0.19 |
chr5_103209022_103210413 | 4.42 |
Mapk10 |
mitogen-activated protein kinase 10 |
705 |
0.75 |
chr14_76420544_76421824 | 4.41 |
Tsc22d1 |
TSC22 domain family, member 1 |
2356 |
0.39 |
chr14_64589664_64590503 | 4.41 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
388 |
0.55 |
chr16_77645925_77646470 | 4.41 |
Mir125b-2 |
microRNA 125b-2 |
76 |
0.58 |
chr13_78196283_78196791 | 4.40 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
164 |
0.91 |
chr10_90576163_90577493 | 4.38 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
13 |
0.99 |
chr13_99446279_99447668 | 4.38 |
Map1b |
microtubule-associated protein 1B |
647 |
0.72 |
chr15_91017138_91018295 | 4.33 |
Kif21a |
kinesin family member 21A |
32102 |
0.16 |
chr1_6734529_6735444 | 4.32 |
St18 |
suppression of tumorigenicity 18 |
116 |
0.98 |
chr5_26904124_26905425 | 4.31 |
Dpp6 |
dipeptidylpeptidase 6 |
79 |
0.98 |
chr4_91374442_91375761 | 4.29 |
Elavl2 |
ELAV like RNA binding protein 1 |
1206 |
0.41 |
chr7_126823319_126824529 | 4.26 |
Fam57b |
family with sequence similarity 57, member B |
621 |
0.41 |
chr5_131532921_131534054 | 4.26 |
Auts2 |
autism susceptibility candidate 2 |
910 |
0.58 |
chr1_81080425_81080966 | 4.25 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
3112 |
0.38 |
chr4_42953037_42954334 | 4.25 |
Dnajb5 |
DnaJ heat shock protein family (Hsp40) member B5 |
591 |
0.62 |
chr9_4793875_4794307 | 4.24 |
Gria4 |
glutamate receptor, ionotropic, AMPA4 (alpha 4) |
1428 |
0.59 |
chr2_28195247_28196182 | 4.23 |
Olfm1 |
olfactomedin 1 |
2621 |
0.32 |
chr3_4798346_4798833 | 4.22 |
1110015O18Rik |
RIKEN cDNA 1110015O18 gene |
119 |
0.97 |
chr12_88724589_88725423 | 4.21 |
Nrxn3 |
neurexin III |
3 |
0.98 |
chr14_100374663_100375528 | 4.21 |
Gm26367 |
predicted gene, 26367 |
43388 |
0.15 |
chr7_99383478_99385192 | 4.19 |
Gdpd5 |
glycerophosphodiester phosphodiesterase domain containing 5 |
1563 |
0.33 |
chr4_148284201_148285628 | 4.18 |
Disp3 |
dispatched RND transporter family member 3 |
3051 |
0.22 |
chr8_31089411_31091663 | 4.16 |
Dusp26 |
dual specificity phosphatase 26 (putative) |
733 |
0.65 |
chr8_106336310_106337932 | 4.14 |
Smpd3 |
sphingomyelin phosphodiesterase 3, neutral |
867 |
0.61 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.2 | 21.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
4.8 | 14.5 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
3.9 | 11.7 | GO:0046684 | response to pyrethroid(GO:0046684) |
3.5 | 10.6 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
3.5 | 28.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
3.3 | 13.2 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
3.2 | 9.5 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
3.1 | 12.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
2.7 | 32.3 | GO:0071625 | vocalization behavior(GO:0071625) |
2.7 | 10.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.6 | 7.7 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
2.5 | 2.5 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
2.4 | 4.9 | GO:0048880 | sensory system development(GO:0048880) |
2.4 | 7.3 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
2.4 | 14.6 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
2.4 | 7.1 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
2.2 | 6.7 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
2.2 | 9.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
2.2 | 11.1 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
2.2 | 10.9 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
2.2 | 4.3 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
2.2 | 6.5 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
2.1 | 6.4 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
2.1 | 10.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
2.1 | 23.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
2.1 | 10.6 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
2.1 | 6.3 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
2.1 | 8.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
2.0 | 8.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
2.0 | 8.1 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
2.0 | 9.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.9 | 7.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.8 | 7.3 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.8 | 3.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.8 | 5.3 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
1.8 | 7.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
1.8 | 35.5 | GO:0031114 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
1.8 | 3.5 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
1.7 | 7.0 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.7 | 12.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
1.7 | 6.9 | GO:0030035 | microspike assembly(GO:0030035) |
1.6 | 4.9 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
1.6 | 8.2 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.6 | 4.8 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.6 | 4.7 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.6 | 4.7 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.6 | 4.7 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.5 | 13.8 | GO:0021860 | pyramidal neuron development(GO:0021860) |
1.5 | 9.0 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
1.5 | 11.9 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.5 | 4.5 | GO:0097503 | sialylation(GO:0097503) |
1.4 | 2.9 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
1.4 | 4.3 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.4 | 5.7 | GO:0021764 | amygdala development(GO:0021764) |
1.4 | 5.5 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.4 | 12.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
1.4 | 2.8 | GO:0072235 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
1.3 | 2.7 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.3 | 3.9 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
1.3 | 3.9 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.3 | 3.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.3 | 10.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.3 | 6.3 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.2 | 3.7 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.2 | 14.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.2 | 2.4 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.2 | 9.7 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.2 | 1.2 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
1.2 | 10.9 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
1.2 | 2.4 | GO:0070253 | somatostatin secretion(GO:0070253) |
1.2 | 3.6 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.2 | 3.6 | GO:0030070 | insulin processing(GO:0030070) |
1.2 | 9.3 | GO:0060074 | synapse maturation(GO:0060074) |
1.1 | 18.4 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.1 | 3.4 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.1 | 3.4 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
1.1 | 2.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.1 | 10.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
1.1 | 13.4 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
1.1 | 1.1 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
1.1 | 1.1 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.1 | 5.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
1.1 | 9.6 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
1.1 | 3.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.1 | 2.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.1 | 18.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.0 | 4.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
1.0 | 8.3 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
1.0 | 7.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.0 | 5.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.0 | 3.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.0 | 2.0 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.0 | 3.9 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
1.0 | 4.9 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.0 | 3.0 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
1.0 | 13.6 | GO:0007019 | microtubule depolymerization(GO:0007019) |
1.0 | 3.9 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
1.0 | 8.7 | GO:0045176 | apical protein localization(GO:0045176) |
1.0 | 8.6 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.9 | 1.9 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.9 | 3.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.9 | 1.8 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.9 | 14.7 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.9 | 10.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.9 | 1.8 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.9 | 5.4 | GO:0007614 | short-term memory(GO:0007614) |
0.9 | 4.5 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.9 | 3.6 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.9 | 44.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.9 | 1.8 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.9 | 7.0 | GO:0008038 | neuron recognition(GO:0008038) |
0.9 | 1.7 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.9 | 4.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.8 | 1.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.8 | 2.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.8 | 1.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.8 | 2.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.8 | 0.8 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.8 | 5.0 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.8 | 14.2 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.8 | 1.6 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.8 | 18.6 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.8 | 1.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.8 | 2.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.8 | 4.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.8 | 4.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.8 | 2.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.8 | 3.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.8 | 0.8 | GO:0061743 | motor learning(GO:0061743) |
0.8 | 3.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.8 | 2.3 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.8 | 3.0 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.8 | 3.0 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.8 | 2.3 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.8 | 3.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.8 | 7.5 | GO:0001964 | startle response(GO:0001964) |
0.7 | 8.2 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.7 | 2.2 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.7 | 2.9 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.7 | 5.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.7 | 0.7 | GO:0021604 | cranial nerve structural organization(GO:0021604) |
0.7 | 0.7 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.7 | 2.1 | GO:0021794 | thalamus development(GO:0021794) |
0.7 | 4.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.7 | 3.5 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.7 | 1.4 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.7 | 2.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.7 | 2.8 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.7 | 1.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.7 | 1.4 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.7 | 2.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.7 | 0.7 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.7 | 3.4 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.7 | 5.4 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.7 | 0.7 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.7 | 14.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.7 | 0.7 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.7 | 2.7 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.7 | 2.0 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.7 | 2.7 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.7 | 2.0 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.7 | 1.3 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.7 | 2.6 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.7 | 80.0 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.6 | 1.9 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.6 | 2.6 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.6 | 2.5 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.6 | 17.9 | GO:0019228 | neuronal action potential(GO:0019228) |
0.6 | 1.8 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.6 | 1.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.6 | 2.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.6 | 3.0 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.6 | 1.2 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.6 | 0.6 | GO:0003140 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) |
0.6 | 4.1 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.6 | 1.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.6 | 1.2 | GO:0007412 | axon target recognition(GO:0007412) |
0.6 | 1.7 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.6 | 1.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.6 | 5.0 | GO:0070977 | bone maturation(GO:0070977) |
0.6 | 12.2 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.6 | 10.0 | GO:0021766 | hippocampus development(GO:0021766) |
0.6 | 2.8 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.6 | 3.9 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.5 | 1.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.5 | 8.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.5 | 3.2 | GO:0015816 | glycine transport(GO:0015816) |
0.5 | 13.6 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.5 | 6.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.5 | 1.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.5 | 3.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.5 | 3.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.5 | 8.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.5 | 3.6 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.5 | 0.5 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.5 | 1.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.5 | 1.0 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.5 | 0.5 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.5 | 2.9 | GO:0050957 | equilibrioception(GO:0050957) |
0.5 | 0.5 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.5 | 2.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.5 | 4.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.5 | 1.9 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.5 | 1.9 | GO:0014028 | notochord formation(GO:0014028) |
0.5 | 4.7 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.5 | 0.9 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.5 | 2.7 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.5 | 0.9 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.4 | 4.0 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.4 | 0.9 | GO:0042891 | antibiotic transport(GO:0042891) |
0.4 | 0.9 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.4 | 2.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.4 | 6.2 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.4 | 2.7 | GO:0060179 | male mating behavior(GO:0060179) |
0.4 | 1.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.4 | 4.4 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.4 | 1.3 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.4 | 1.8 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.4 | 1.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.4 | 2.2 | GO:0086015 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.4 | 3.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.4 | 0.8 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.4 | 0.4 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.4 | 0.4 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
0.4 | 24.7 | GO:0007612 | learning(GO:0007612) |
0.4 | 1.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.4 | 5.4 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.4 | 1.3 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.4 | 3.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.4 | 4.6 | GO:0046847 | filopodium assembly(GO:0046847) |
0.4 | 12.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.4 | 1.6 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.4 | 3.2 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.4 | 1.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.4 | 0.8 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.4 | 2.8 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.4 | 0.8 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.4 | 7.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.4 | 0.4 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.4 | 0.8 | GO:0032095 | regulation of response to food(GO:0032095) |
0.4 | 1.9 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.4 | 24.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.4 | 0.7 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.4 | 1.9 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.4 | 0.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.4 | 0.7 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.4 | 0.7 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.4 | 2.9 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.4 | 1.1 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.4 | 2.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.4 | 0.7 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.4 | 1.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.4 | 0.7 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.4 | 0.4 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.4 | 0.7 | GO:0006868 | glutamine transport(GO:0006868) |
0.3 | 1.0 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.3 | 0.3 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.3 | 1.0 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 0.7 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.3 | 0.7 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.3 | 2.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.3 | 0.3 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.3 | 0.3 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.3 | 1.0 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.3 | 1.0 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.3 | 0.3 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.3 | 2.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.3 | 1.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.3 | 0.7 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.3 | 0.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.3 | 1.0 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.3 | 0.7 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.3 | 9.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 1.0 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.3 | 4.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.3 | 1.6 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.3 | 1.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.3 | 1.0 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 0.9 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 0.9 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.3 | 0.3 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 0.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 1.5 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.3 | 0.3 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.3 | 3.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 0.6 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.3 | 0.3 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.3 | 0.6 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.3 | 0.6 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.3 | 0.3 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.3 | 1.4 | GO:0032098 | regulation of appetite(GO:0032098) |
0.3 | 0.6 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.3 | 0.9 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.3 | 0.3 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.3 | 1.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 1.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 2.2 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.3 | 3.4 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.3 | 0.6 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.3 | 0.3 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.3 | 1.1 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 0.3 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.3 | 0.5 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.3 | 0.5 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 1.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 0.3 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.3 | 1.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.3 | 4.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.3 | 1.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 1.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.3 | 0.3 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.3 | 0.5 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.3 | 1.8 | GO:0007616 | long-term memory(GO:0007616) |
0.3 | 0.3 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.3 | 1.3 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.3 | 1.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.3 | 1.0 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.3 | 0.8 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.2 | 2.5 | GO:0001967 | suckling behavior(GO:0001967) |
0.2 | 0.5 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.2 | 0.7 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 2.7 | GO:0055062 | phosphate ion homeostasis(GO:0055062) trivalent inorganic anion homeostasis(GO:0072506) |
0.2 | 0.5 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 0.5 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) regulation of sodium-dependent phosphate transport(GO:2000118) |
0.2 | 5.9 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 1.4 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 1.2 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.2 | 0.9 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 1.8 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 2.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 0.4 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.2 | 0.7 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 4.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.9 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 0.7 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.2 | 0.7 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 1.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.2 | 0.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 3.7 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.2 | 8.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 3.2 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.2 | 0.6 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.2 | 0.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.2 | 0.2 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 1.1 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.2 | 1.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.2 | 0.8 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 1.5 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.2 | 0.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 2.5 | GO:0046931 | pore complex assembly(GO:0046931) |
0.2 | 0.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 7.8 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 0.6 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 0.6 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 1.0 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.2 | 0.6 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.4 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.2 | 0.4 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.2 | 0.2 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.2 | 0.6 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 1.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.2 | 0.4 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.2 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.2 | 0.2 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 0.6 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 1.2 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.2 | 0.4 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.2 | 1.7 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.2 | 0.2 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.2 | 0.9 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.2 | 0.4 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 0.6 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 0.7 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.2 | 0.2 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.2 | 0.2 | GO:0072553 | terminal button organization(GO:0072553) |
0.2 | 1.3 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 0.2 | GO:0001975 | response to amphetamine(GO:0001975) |
0.2 | 0.4 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.2 | 4.5 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.2 | 0.4 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.2 | 0.7 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 0.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 0.7 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.2 | 0.3 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.2 | 0.3 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.2 | 0.3 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.7 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.2 | 0.9 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 1.9 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.2 | 0.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.2 | 0.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.2 | 0.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 0.3 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.2 | 0.2 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.2 | 13.8 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.2 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 1.0 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.2 | 0.3 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.2 | 0.2 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.2 | 0.6 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 0.2 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.2 | 0.8 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.2 | 0.2 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 0.6 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
0.2 | 1.8 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.2 | 0.3 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.2 | 0.5 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.2 | 0.2 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.2 | 0.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.1 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.1 | 0.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.9 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.1 | 2.3 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 1.5 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.1 | GO:1903800 | regulation of Golgi inheritance(GO:0090170) positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 6.1 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.1 | 0.4 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.1 | 0.4 | GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.1 | 0.1 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.1 | 0.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 0.6 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.3 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.1 | 1.0 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.3 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 1.1 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.1 | 1.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 1.5 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.3 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 1.5 | GO:0046755 | multi-organism membrane organization(GO:0044803) viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.1 | 0.4 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.8 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.7 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.4 | GO:0042220 | response to cocaine(GO:0042220) |
0.1 | 0.1 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.4 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.3 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 1.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.5 | GO:0035989 | tendon development(GO:0035989) |
0.1 | 0.3 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.4 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 1.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.4 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.6 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.1 | 0.6 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 1.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.9 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.4 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.4 | GO:0010042 | response to manganese ion(GO:0010042) |
0.1 | 0.7 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.4 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.7 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.6 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.1 | 1.1 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.4 | GO:0015824 | proline transport(GO:0015824) |
0.1 | 0.4 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.4 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 0.2 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.1 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) |
0.1 | 1.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 1.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.7 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.1 | 0.4 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.2 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.1 | 0.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.3 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.1 | 0.3 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.7 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.1 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.1 | 1.1 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.3 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.2 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.6 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.4 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 1.0 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.5 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.6 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 0.4 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.2 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 1.5 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.3 | GO:0042160 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.1 | 0.2 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 0.3 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.1 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 0.9 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.1 | 0.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.1 | GO:0051794 | regulation of catagen(GO:0051794) |
0.1 | 0.7 | GO:0032094 | response to food(GO:0032094) |
0.1 | 3.9 | GO:0007409 | axonogenesis(GO:0007409) |
0.1 | 4.0 | GO:0010976 | positive regulation of neuron projection development(GO:0010976) |
0.1 | 4.7 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.5 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 1.4 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.1 | 0.2 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.2 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.1 | 0.2 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.1 | 0.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 1.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.3 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 1.3 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.1 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) |
0.1 | 0.7 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.3 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.1 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.1 | 0.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.4 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.8 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.5 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.1 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 2.0 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 2.0 | GO:0016358 | dendrite development(GO:0016358) |
0.1 | 0.6 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.2 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.1 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.2 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.3 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.9 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
0.1 | 0.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.4 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.2 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.1 | 0.2 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.1 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.8 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.1 | GO:0021546 | rhombomere development(GO:0021546) |
0.1 | 0.2 | GO:0072017 | distal tubule development(GO:0072017) |
0.1 | 0.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.2 | GO:2000410 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.1 | 0.6 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
0.1 | 0.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 1.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.2 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.1 | GO:1902991 | regulation of amyloid precursor protein catabolic process(GO:1902991) |
0.1 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.1 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.6 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.1 | 0.1 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.3 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.1 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 0.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.5 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.5 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.1 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.1 | 0.6 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.1 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.1 | 0.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 0.1 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 0.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.4 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.1 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.1 | 0.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.7 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.2 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.1 | 0.1 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 0.7 | GO:0051905 | establishment of pigment granule localization(GO:0051905) |
0.1 | 0.1 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.1 | 0.2 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.1 | 0.3 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.1 | 0.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.2 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.1 | 0.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.1 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.4 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.6 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.1 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 0.5 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.1 | 0.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.2 | GO:0010458 | exit from mitosis(GO:0010458) |
0.1 | 0.2 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.0 | 0.1 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.0 | 0.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 1.1 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.0 | 0.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.2 | GO:0015867 | ATP transport(GO:0015867) |
0.0 | 1.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.1 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 0.1 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.0 | 0.3 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.4 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 0.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.0 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 0.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.0 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.0 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.0 | 0.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.0 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.0 | 2.2 | GO:0048812 | neuron projection morphogenesis(GO:0048812) |
0.0 | 0.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.0 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 0.9 | GO:0045665 | negative regulation of neuron differentiation(GO:0045665) |
0.0 | 0.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.2 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.0 | 0.3 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.0 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.5 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.0 | 0.1 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.0 | 0.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.0 | 0.1 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.0 | 0.1 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.0 | 0.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.1 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.0 | 0.1 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.0 | 0.3 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.0 | 0.0 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.0 | 0.0 | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity(GO:1901020) |
0.0 | 0.1 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.0 | 1.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.2 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.1 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.0 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.0 | 0.0 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.0 | 0.1 | GO:0044038 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.0 | 0.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.0 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.0 | 0.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.0 | GO:2001138 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.0 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.0 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.0 | 0.0 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.0 | 0.0 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.0 | 0.3 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.1 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.0 | 0.2 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.1 | GO:2000727 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) positive regulation of cardiac muscle cell differentiation(GO:2000727) |
0.0 | 0.1 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.0 | 0.0 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.0 | GO:0002477 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
0.0 | 0.1 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.0 | 0.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 1.9 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.0 | 0.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.0 | 0.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.0 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.0 | 0.0 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.0 | 0.0 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.0 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.0 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.0 | 0.2 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.0 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.0 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.0 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.1 | GO:0045837 | negative regulation of membrane potential(GO:0045837) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.6 | GO:0097451 | glial limiting end-foot(GO:0097451) |
2.5 | 7.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
2.3 | 13.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
2.3 | 20.5 | GO:0016342 | catenin complex(GO:0016342) |
2.2 | 26.7 | GO:0043194 | axon initial segment(GO:0043194) |
2.2 | 2.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
2.1 | 12.6 | GO:0032584 | growth cone membrane(GO:0032584) |
2.0 | 18.2 | GO:0005883 | neurofilament(GO:0005883) |
2.0 | 9.9 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
2.0 | 15.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.9 | 16.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.9 | 35.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.7 | 17.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.6 | 12.5 | GO:0071437 | invadopodium(GO:0071437) |
1.5 | 12.3 | GO:0043083 | synaptic cleft(GO:0043083) |
1.4 | 36.9 | GO:0044295 | axonal growth cone(GO:0044295) |
1.4 | 9.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.3 | 9.3 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.1 | 3.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.0 | 47.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.0 | 32.8 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
1.0 | 20.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.0 | 3.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.0 | 43.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.9 | 26.9 | GO:0031941 | filamentous actin(GO:0031941) |
0.9 | 12.9 | GO:0071565 | nBAF complex(GO:0071565) |
0.9 | 9.0 | GO:0030673 | axolemma(GO:0030673) |
0.8 | 2.5 | GO:0072534 | perineuronal net(GO:0072534) |
0.8 | 10.7 | GO:0043196 | varicosity(GO:0043196) |
0.8 | 7.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.8 | 11.3 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.8 | 8.9 | GO:0035102 | PRC1 complex(GO:0035102) |
0.8 | 0.8 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.8 | 9.8 | GO:0031527 | filopodium membrane(GO:0031527) |
0.7 | 6.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.7 | 11.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.7 | 20.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.7 | 2.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.7 | 2.0 | GO:0097427 | microtubule bundle(GO:0097427) |
0.7 | 1.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.6 | 3.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.6 | 4.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.6 | 2.9 | GO:0044327 | dendritic spine head(GO:0044327) |
0.6 | 1.7 | GO:0033269 | internode region of axon(GO:0033269) |
0.6 | 1.1 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.6 | 12.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.6 | 5.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.6 | 4.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.6 | 0.6 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.5 | 1.6 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.5 | 1.6 | GO:0097513 | myosin II filament(GO:0097513) |
0.5 | 4.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.5 | 3.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.5 | 70.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.5 | 3.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.5 | 4.1 | GO:0031045 | dense core granule(GO:0031045) |
0.5 | 0.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.5 | 1.4 | GO:0033010 | paranodal junction(GO:0033010) |
0.5 | 1.9 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.4 | 0.9 | GO:0097441 | basilar dendrite(GO:0097441) |
0.4 | 29.6 | GO:0043204 | perikaryon(GO:0043204) |
0.4 | 30.9 | GO:0030426 | growth cone(GO:0030426) |
0.4 | 20.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.4 | 13.2 | GO:0030175 | filopodium(GO:0030175) |
0.4 | 2.0 | GO:0097433 | dense body(GO:0097433) |
0.4 | 0.4 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.4 | 18.1 | GO:0043195 | terminal bouton(GO:0043195) |
0.4 | 2.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.4 | 1.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.4 | 7.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.3 | 0.3 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 4.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 0.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 1.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 1.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.3 | 4.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 16.2 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.3 | 0.9 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 18.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 1.8 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.3 | 4.1 | GO:0097060 | synaptic membrane(GO:0097060) |
0.3 | 1.1 | GO:0043203 | axon hillock(GO:0043203) |
0.3 | 0.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.3 | 4.0 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.3 | 2.0 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 0.5 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 0.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 0.2 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.2 | 0.7 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 0.9 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 0.6 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 0.6 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 0.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 0.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 2.7 | GO:0031011 | Ino80 complex(GO:0031011) |
0.2 | 0.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 28.8 | GO:0030424 | axon(GO:0030424) |
0.2 | 0.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 0.4 | GO:0097449 | astrocyte projection(GO:0097449) |
0.2 | 1.6 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 0.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 1.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 1.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 0.2 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 2.7 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 0.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 0.5 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.2 | 1.0 | GO:0001652 | granular component(GO:0001652) |
0.2 | 1.0 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 0.8 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 6.7 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.2 | 0.8 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 1.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 1.6 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.1 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.6 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 43.6 | GO:0043005 | neuron projection(GO:0043005) |
0.1 | 0.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 0.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 1.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.6 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.4 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.3 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.1 | 0.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.3 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 0.7 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.1 | 0.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.5 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.4 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 1.6 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.5 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.5 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.7 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 0.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 1.1 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 2.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 1.0 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.4 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.2 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 0.3 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.2 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.8 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 2.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 7.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.2 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 5.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.6 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.2 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.1 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 4.2 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 0.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.2 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.4 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.4 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 0.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 0.1 | GO:0097346 | INO80-type complex(GO:0097346) |
0.0 | 4.8 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 1.0 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.2 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.0 | 0.0 | GO:0032010 | phagolysosome(GO:0032010) |
0.0 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.5 | GO:0044297 | cell body(GO:0044297) |
0.0 | 0.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 4.3 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.2 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.9 | 29.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
5.3 | 26.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
4.2 | 12.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
3.7 | 7.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.3 | 9.9 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
2.8 | 13.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
2.5 | 7.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
2.5 | 12.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.1 | 8.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.0 | 14.2 | GO:0003680 | AT DNA binding(GO:0003680) |
2.0 | 2.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
2.0 | 9.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
2.0 | 5.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.9 | 5.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.8 | 5.3 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.7 | 10.4 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.7 | 13.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.5 | 21.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.5 | 18.1 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.5 | 9.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.4 | 7.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.4 | 11.5 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.4 | 8.6 | GO:0048495 | Roundabout binding(GO:0048495) |
1.4 | 5.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.3 | 15.9 | GO:0031005 | filamin binding(GO:0031005) |
1.3 | 3.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.3 | 11.7 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.3 | 3.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.2 | 18.4 | GO:0031402 | sodium ion binding(GO:0031402) |
1.2 | 8.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.2 | 5.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.1 | 3.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.1 | 4.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.1 | 6.5 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.1 | 11.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.0 | 8.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
1.0 | 3.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.0 | 18.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
1.0 | 8.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
1.0 | 2.9 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
1.0 | 3.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.9 | 3.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.9 | 2.6 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.9 | 2.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.9 | 1.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.8 | 2.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.8 | 9.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.8 | 2.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.8 | 5.7 | GO:0043495 | protein anchor(GO:0043495) |
0.8 | 4.8 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.8 | 8.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.8 | 2.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.8 | 8.8 | GO:0005522 | profilin binding(GO:0005522) |
0.7 | 3.0 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.7 | 3.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.7 | 13.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.7 | 3.7 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.7 | 3.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.7 | 17.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.7 | 2.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.7 | 6.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.7 | 0.7 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.7 | 4.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.7 | 14.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.7 | 2.8 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.7 | 1.3 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.7 | 6.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.7 | 7.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.7 | 7.2 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.7 | 6.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.7 | 2.6 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.7 | 14.4 | GO:0052713 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.6 | 13.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.6 | 1.9 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.6 | 3.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.6 | 8.9 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.6 | 0.6 | GO:0048030 | disaccharide binding(GO:0048030) |
0.6 | 1.9 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.6 | 1.8 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.6 | 7.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.6 | 1.8 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.6 | 12.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.6 | 3.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.6 | 0.6 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.6 | 17.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.6 | 13.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.6 | 0.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.6 | 2.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.6 | 11.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.5 | 3.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.5 | 2.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.5 | 1.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.5 | 1.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.5 | 1.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.5 | 1.0 | GO:0035939 | microsatellite binding(GO:0035939) |
0.5 | 3.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.5 | 1.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.5 | 1.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.5 | 2.5 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.5 | 0.5 | GO:0051378 | serotonin binding(GO:0051378) |
0.5 | 6.9 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.5 | 1.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.5 | 5.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.5 | 7.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.5 | 5.7 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.5 | 0.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.5 | 15.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.5 | 1.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.5 | 2.8 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.5 | 1.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.4 | 1.8 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.4 | 1.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.4 | 11.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.4 | 8.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.4 | 3.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.4 | 2.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.4 | 1.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.4 | 11.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.4 | 0.8 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.4 | 6.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.4 | 2.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.4 | 2.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.4 | 0.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.4 | 0.8 | GO:0097016 | L27 domain binding(GO:0097016) |
0.4 | 7.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.4 | 1.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.4 | 5.4 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.4 | 3.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.4 | 0.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.4 | 1.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 0.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 3.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.4 | 7.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.4 | 4.8 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 16.8 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.4 | 1.5 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 0.4 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.4 | 0.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.4 | 9.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.4 | 2.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.4 | 1.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.4 | 1.4 | GO:0097001 | ceramide binding(GO:0097001) |
0.4 | 0.7 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.3 | 3.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 0.3 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.3 | 1.0 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 0.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 2.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 10.9 | GO:0005262 | calcium channel activity(GO:0005262) |
0.3 | 1.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 8.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.3 | 4.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 2.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 8.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 0.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 1.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.3 | 6.9 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.3 | 3.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 1.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.3 | 1.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 5.1 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.3 | 0.9 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.3 | 2.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 1.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 8.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 3.8 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.3 | 2.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.3 | 4.0 | GO:0030275 | LRR domain binding(GO:0030275) |
0.3 | 5.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.3 | 1.7 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.3 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.3 | 3.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 0.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.3 | 0.5 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.3 | 0.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.3 | 18.8 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.3 | 4.5 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 1.9 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 53.6 | GO:0015631 | tubulin binding(GO:0015631) |
0.3 | 6.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 2.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.3 | 0.8 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.3 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 0.8 | GO:0005119 | smoothened binding(GO:0005119) |
0.3 | 3.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 3.7 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.2 | 0.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 4.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 1.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 0.9 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.2 | 0.7 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 0.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.2 | 1.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 1.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 0.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 2.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 5.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 3.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 0.6 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 0.8 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.2 | 0.8 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 0.2 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 2.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 1.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 0.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 0.8 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 0.6 | GO:0033265 | choline binding(GO:0033265) |
0.2 | 0.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 0.8 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.2 | 0.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 0.6 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 1.9 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 0.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 2.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 3.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 1.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 0.3 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 0.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.7 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 1.3 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.7 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 0.8 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.2 | 0.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 0.5 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.2 | 0.3 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 1.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 0.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 0.5 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 0.9 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 0.6 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 3.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 0.6 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.2 | 1.1 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.2 | 0.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 2.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 1.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 1.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 0.3 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.1 | 2.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 1.0 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.4 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.1 | 3.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 18.3 | GO:0003729 | mRNA binding(GO:0003729) |
0.1 | 1.9 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 2.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 5.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 0.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 2.1 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.3 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.1 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.1 | 1.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 1.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.5 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 1.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.4 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.7 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.3 | GO:0018562 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 0.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 2.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.9 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 1.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.3 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.1 | 0.9 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.2 | GO:0017002 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.1 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 1.0 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.8 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 1.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.8 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 3.9 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 1.6 | GO:0052634 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.1 | 0.1 | GO:0018592 | fluorene oxygenase activity(GO:0018585) mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 0.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.3 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.2 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.1 | 1.4 | GO:0034882 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.1 | 0.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.1 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.1 | 1.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 0.4 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 1.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.4 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.3 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 1.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 11.7 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.4 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.8 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.5 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 3.0 | GO:0005261 | cation channel activity(GO:0005261) |
0.1 | 0.6 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.3 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.1 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.2 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.2 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.5 | GO:0046030 | inositol trisphosphate phosphatase activity(GO:0046030) |
0.1 | 1.0 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.2 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.1 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.1 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.3 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 0.5 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.0 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.0 | 0.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.0 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.3 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.0 | 0.3 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 1.5 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 1.4 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 1.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.6 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 1.0 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.1 | GO:0048045 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.0 | 0.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.7 | GO:0052693 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.0 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.1 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.0 | 0.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.0 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.9 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.4 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.0 | 0.5 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.4 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.0 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.0 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 26.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.7 | 11.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.6 | 8.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.6 | 13.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.6 | 5.8 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.6 | 15.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 12.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.4 | 11.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 12.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.4 | 14.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 4.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 9.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 5.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 2.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 13.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.3 | 5.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 4.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 3.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 7.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 5.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 1.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 3.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 5.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 8.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 1.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 4.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 2.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 2.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 2.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 3.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 2.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 2.3 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 0.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.4 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.6 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 34.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.3 | 16.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.3 | 21.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
1.3 | 22.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.3 | 19.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.3 | 10.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.2 | 8.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.2 | 13.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.1 | 13.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.1 | 24.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.0 | 11.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.0 | 3.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.9 | 4.5 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.9 | 8.9 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.8 | 17.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.8 | 15.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.8 | 19.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.7 | 7.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.6 | 7.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.6 | 8.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.6 | 6.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.6 | 8.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.6 | 15.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.6 | 11.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.6 | 6.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.6 | 10.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.6 | 23.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.6 | 7.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.5 | 6.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.5 | 7.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.5 | 6.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.5 | 5.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.4 | 1.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.4 | 12.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.4 | 19.3 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.4 | 1.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.4 | 3.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 8.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.4 | 4.3 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.4 | 2.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 1.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 2.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 6.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.3 | 5.0 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.3 | 0.3 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.3 | 0.3 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.2 | 2.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 2.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 1.6 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.2 | 4.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 0.4 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.2 | 0.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 0.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 0.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 0.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 1.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 6.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 1.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 1.7 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.2 | 2.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 2.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 9.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 2.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 17.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 3.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 4.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.4 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 0.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 0.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.6 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 3.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.8 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.6 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 1.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.6 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 1.7 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.1 | 0.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 0.7 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.0 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.0 | 0.3 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.6 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 1.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.9 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.7 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.0 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.0 | 0.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |